Skip to main content
GANX logo

GANX · Gain Therapeutics, Inc.

Track GANX — free
$1.91 -0.09 (-4.50%)
Market Cap
$87.51M
Shares
43.64M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

GANX Short Interest Forecast

Equibles' model estimates 2,853,303 shares sold short for the August 31, 2026 settlement, -3.4% versus the latest reported position. This model prediction uses FINRA data through August 21, 2026; FINRA's official release is expected September 10, 2026.

Model estimate

Expected Aug 31 short interest

as of Aug 21
2,853,303 -3.4% vs reported
The latest estimate appears in the chart below. Official release expected Sep 10. Methodology
Short Squeeze Score
71/100
Short interest 7.4% of shares — P83 Days to cover 6.7 — P78 Price vs VWAP +6.1% — P71 Short-volume trend +1.5% — P57 Short interest change -10.4% — P27 Worst FTD 0.18% of shares — P88

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-31). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-09-15 Scheduled
FINRA publishes Sep 24
2026-08-31 Scheduled
FINRA publishes Sep 10
2026-08-14 2,952,391 3,213,359 -260,968 4.89
2026-07-31 3,213,359 3,588,085 -374,726 6.65
2026-07-15 3,588,085 3,608,175 -20,090 4.05
2026-06-30 3,608,175 3,869,330 -261,155 1.81
2026-06-15 3,869,330 3,198,541 +670,789 6.06
2026-05-29 3,198,541 3,160,772 +37,769 3.86
2026-05-15 3,160,772 3,442,408 -281,636 7.22
2026-04-30 3,442,408 3,331,182 +111,226 6.33
2026-04-15 3,331,182 3,282,560 +48,622 5.79
2026-03-31 3,282,560 2,873,797 +408,763 4.03
2026-03-13 2,873,797 2,883,705 -9,908 3.59
2026-02-27 2,883,705 3,039,619 -155,914 4.08
2026-02-13 3,039,619 2,976,352 +63,267 5.92
2026-01-30 2,976,352 2,482,134 +494,218 3.74
2026-01-15 2,482,134 2,666,410 -184,276 1.83
2025-12-31 2,666,410 2,073,310 +593,100 1.00
2025-12-15 2,073,310 1,260,732 +812,578 1.50
2025-11-28 1,260,732 1,781,339 -520,607 1.28
2025-11-14 1,781,339 910,705 +870,634 1.16
2025-10-31 910,705 1,270,541 -359,836 1.37
2025-10-15 1,270,541 422,327 +848,214 1.13
2025-09-30 422,327 377,057 +45,270 1.00
2025-09-15 377,057 233,336 +143,721 1.00
2025-08-29 233,336 210,923 +22,413 1.00
Showing 1–24 of 24 settlements
Key facts CIK 1819411 CUSIP 36269B105 13F (30d) 45 filings 45 filers Visit website Investor relations